Latest news by search query "astrazeneca covid 19 vaccine"

LONDON (AP) - AstraZeneca recorded a big jump in revenue on Thursday as it begins to take a profit from its coronavirus vaccine for the first time.The company recorded full-year revenues of $37.4 billion, an increase of 38% from the year before at constant exchange rates. Part of the boost came from $4 billion in sales of its COVID-19 vaccine, developed with the University of Oxford.Despite rising revenue, AstraZeneca reported a pre-tax loss of $265 million due to costs from its purchase of U.S.

Usa Sweden city Oxford covid-19 vaccine Coronavirus

COVID-19: Health Canada adds autoimmune disorder warning to AstraZeneca, J&J vaccines

Health Canada has updated its labels for the AstraZeneca and the Johnson & Johnson COVID-19 vaccines to add immune thrombocytopenia (ITP) as a potential side-effect.

Canada covid-19 vaccine Health

Health Canada adds autoimmune disorder warning to AstraZeneca, J&J COVID-19 vaccines

Health Canada is updating the labels for the AstraZeneca and Johnson & Johnson COVID-19 vaccines to add immune thrombocytopenia (ITP), an autoimmune condition, as a potential side effect.In a statement on Tuesday, the agency said very rare cases of ITP have been reported internationally after receiving the Vaxzevria (AstraZeneca) and Janssen (J&J) COVID-19 vaccines.ITP is a disorder that can cause easy or excessive bruising and bleeding, which results from unusually low blood platelet levels. Why rare blood clots could be a side effect of AstraZeneca COVID-19 vaccine Such cases typically occur within 28 days after vaccination, the agency said.

Canada covid-19 vaccine J&J

Combining AstraZeneca, mRNA Covid-19 vaccines is effective: Danish study

COPENHAGEN :

India Denmark city Copenhagen covid-19 vaccine Health

AstraZeneca to seek US approval of COVID-19 vaccine in 2nd half of 2021

LONDON - AstraZeneca said Thursday that it intends to seek U.S. authorization for its COVID-19 vaccine in the second half of this year, offering a new timetable for the much-delayed application.The Anglo-Swedish drugmaker announced the schedule as it released second-quarter financial results, which showed that the company and its sub-licensees delivered more than 700 million doses of the vaccine to over 170 countries in the first half of this year.

Usa Sweden covid-19 vaccine Health

J&J, AstraZeneca explore covid-19 vaccine modification in response to rare blood clots

Johnson & Johnson, AstraZeneca PLC and the University of Oxford, along with outside scientists, are conducting early-stage research into whether potential modifications of their Covid-19 vaccines could reduce or eliminate the risk of rare but serious blood clots associated with the shots, according to people close to the process.

India Canada city Oxford virus covid-19 vaccine Health

AstraZeneca COVID-19 vaccine doses 94% protective against death in 65+ group: U.K. data

COVID-19 vaccine gives an estimated 94 per cent protection against death from the coronavirus disease in people over 65, Public Health England said on Thursday in a weekly surveillance report of real-world data.

Health England India Canada covid-19 death vaccine Coronavirus

Single dose of Pfizer, AstraZeneca Covid vaccines offer 60% protection: Study

Pfizer or AstraZeneca Covid-19 vaccine offers around 60 per cent protection against infection from SARS-CoV-2 in adults aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

India Britain city London covid-19 vaccine infection

COVID-19: London, Ont., region pivots from AstraZeneca to Moderna vaccines

Middlesex-London Health Unit‘s medical officer of health is reassuring the public that if they chose to receive the Oxford-AstraZeneca COVID-19 vaccine, they “made the right choice.”Dr. Chris Mackie’s comments come a day after the province announced it was pausing the its use due to safety- and supply-related issues.It also comes ahead of an expected increase in shipments of Moderna‘s vaccine, to be made available through select primary care providers as well as some pharmacies.

Chris Mackie covid-19 vaccine

Brazil suspends use of AstraZeneca Covid-19 vaccine in pregnant women

Never miss a story! Stay connected and informed with Mint. Download our App Now!!

India Brazil covid-19 information vaccine

EU doesn’t renew order for AstraZeneca's COVID-19 vaccine after inking deal with Pfizer

COLOGNE, GERMANY - MAY 09: Syringes of AstraZeneca vaccination against Covid-19 are pictured inside the city's main mosque, which has temporarily become a mass vaccination center, during the coronavirus pandemic on May 09, 2021 in Cologne, Germany. C The EU Commission did not renew its order for AstraZeneca's COVID-19 vaccine, the European Union’s Internal Market Commissioner said Sunday."We have not renewed the order for after June.

Germany Eu covid-19 vaccine Coronavirus

Symptoms of B.C. woman who developed rare blood clot following AstraZeneca COVID-19 vaccine

Provincial health officer Dr. Bonnie Henry confirms B.C.’s first case of a rare blood clot disorder in a person who received the AstraZeneca vaccine, a woman in her 40s.

Bonnie Henry Britain vaccine symptoms

Quebec reports 1st AstraZeneca COVID-19 vaccine-related death due to blood clot

Quebec’s National Director of Public Health Dr. Horacio Arruda announced Tuesday the first death related to AstraZeneca’s COVID-19 vaccine for a 54-year-old woman.

Horacio Arruda covid-19 death vaccine

EU sues AstraZeneca over covid-19 vaccine shortfall

This story has been published from a wire agency feed without modifications to the text.Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

India Eu covid-19 vaccine

EU launches legal action against COVID-19 vaccine maker AstraZeneca over dose shortage

HAYWARDS HEATH, ENGLAND - JANUARY 02: Doses of the Oxford University/AstraZeneca Covid-19 vaccine arrive at the Princess Royal Hospital in Haywards Heath on January 02, 2021 in West Sussex, United Kingdom. The UK has 530,000 doses available for roll- BRUSSELS (AP) - The European Union's executive branch said Monday that it has launched legal action against coronavirus vaccine-maker AstraZeneca for failing to respect the terms of its contract with the 27-nation bloc.The AstraZeneca vaccine has been central to Europe’s immunization campaign, and a linchpin in the global strategy to get vaccines to poorer countries.

Royal Hospital Britain Eu city Brussels county Sussex covid-19 vaccine Coronavirus

Why does AstraZeneca vaccine guidance keep changing? Experts weigh in

AstraZeneca’s COVID-19 vaccine.On Monday, Canada’s National Advisory Committee on Immunization (NACI) issued new guidelines recommending that the shot should not be administered to people under the age of 55 due to concerns over reports of blood clots.

Covid Vaccine Canada

WHO green-lights AstraZeneca COVID vaccine for urgent use

The World Health Organization (WHO) today announced that the AstraZeneca-Oxford COVID-19 vaccine made in two different countries is listed for emergency use, clearing the final hurdle for doses to be distributed by the COVAX program.

covid-19 vaccine

WHO gives AstraZeneca-Oxford COVID-19 vaccine emergency use approval

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

covid-19 vaccine

AstraZeneca expects new version of COVID-19 vaccine by autumn

AstraZeneca said Thursday it expects to have a new version of its COVID-19 vaccine ready for use by this autumn as drugmakers respond to concerns about emerging variants of the disease that may be more transmissible or resistant to existing vaccines.The Anglo-Swedish company, which makes a vaccine developed by the University of Oxford, said it is working with the university’s scientists to adapt the shot to combat new variants. Researchers began this work months ago when the variants were first detected, said Mene Pangalos, head of biopharmaceuticals research for AstraZeneca.

Sweden city Oxford Coronavirus Vaccine COVID-19 Vaccine Coronavirus

The Oxford/AstraZeneca COVID-19 vaccine: what you need to know

The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued interim recommendations for use of the Oxford/AstraZeneca COVID-19 vaccine (AZD1222).

covid-19 recommendations vaccine

AstraZeneca COVID-19 vaccine rollout halted in South Africa after shot appears less effective against variant

JOHANNESBURG (AP) - South Africa is considering giving a COVID-19 vaccine that is still in the testing phase to health workers, after suspending the rollout of another shot that preliminary data indicated may be only minimally effective against the mutated form of the virus dominating the country.The country was scrambling Monday to come up with a new vaccination strategy after it halted use of the AstraZeneca vaccine — which is cheaper and easier to handle than some others and which many had hoped would be crucial to combatting the pandemic in developing countries.

South Africa city Johannesburg covid-19 testing vaccine

South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant

Jon CohenScience's COVID-19 reporting is supported by the Heising-Simons Foundation.Another COVID-19 vaccine has run into trouble in South Africa, showing less protection there than elsewhere because a SARS-CoV-2 variant that can apparently dodge key antibodies has become widespread.

South Africa city Oxford covid-19 vaccine infection

France begins distributing AstraZeneca COVID vaccine amid UK variant warning

Paris [France]: France began distributing the AstraZeneca's COVID-19 vaccine on Saturday as epidemiologist Arnaud Fontanet warned the coronavirus variant B.1.1.7 -- first identified in the UK - could be dominant in the country by March."Between January 7-8, [the B.1.1.7 Variant] accounted for 3.3 per cent of new contaminations; on January 27, it was 14 per cent according to preliminary results from the second flash study," Fontanet, who is also a member of the Scientific Council advising the French government on the pandemic, said in an interview with Le Journal du Dimanche quoted by CNN."This progression confirms it is 50 to 60 per cent more transmissible than the 2020 virus.

Britain France covid-19 vaccine

New AstraZeneca COVID vaccine data ease worries over 2nd-dose delay

New data from clinical trials of the AstraZeneca-Oxford University COVID-19 vaccine suggest it provides strong protection after the first of two doses and could slow the spread of the virus, according to a new preprint study.

Britain South Africa Brazil covid-19 vaccine

Italy's medicines agency approves AstraZeneca's Covid-19 vaccine: Report

AstraZeneca and Oxford University, a source from the medicines regulator said.The vaccine, which received a green light by the European Medicines Agency (EMA) on Friday, is the third cleared for use in the European Union. The others approved for use in the EU are the vaccine produced by Pfizer and BioNTech and one by Moderna.The Aifa source said the regulator recommended "the preferential use" of the vaccine in people between the ages of 18 and 55 years old.EMA had said there were not yet enough results for people over the age of 55 to determine how well it worked in that group.

Italy Eu covid-19 vaccine medicines

Behind AstraZeneca’s covid-19 vaccine stumble

Also Read | Covid vaccination faces slow startThe setbacks, which come on the eve of a decision from regulators whether to recommend the shot for use in Europe, suggest AstraZeneca is falling behind in the vaccine arms race. The company has relatively little experience in vaccines, a tricky, typically low-margin niche in the global pharmaceuticals industry.

virus covid-19 vaccine

COVID-19 vaccine: AstraZeneca seeks EU approval for Oxford vaccine

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Eu covid-19 vaccine

U.K. jumps ahead in global COVID-19 vaccine race, rolls out 1st AstraZeneca shots

COVID-19, ramping up its immunization program by giving the first shots in the world from the vaccine created by Oxford University and pharmaceutical giant AstraZeneca.Dialysis patient Brian Pinker, 82, was the first to get the new vaccine shot, administered by the chief nurse at Oxford University Hospital. Pinker said he was so pleased and that he can “now really look forward to celebrating my 48th wedding anniversary with my wife Shirley later this year.”Since Dec.

Germany Britain covid-19 vaccine Coronavirus

First people will receive Oxford University/AstraZeneca Covid-19 vaccine today

coronavirus vaccine today as the NHS rapidly extends the roll out programmes across Britain.The NHS is the first health service in the world to deploy the jab, which was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) last week.The Oxford jab is the only current approved vaccine which can be stored at standard fridge temperatures, between 2C and 8C.The Pfizer vaccine, already being deployed in the UK, has to be kept at -70C.

Britain hospital vaccine NHS

India OKs AstraZeneca and locally-made COVID-19 vaccines

NEW DELHI – India authorized two COVID-19 vaccines on Sunday, paving the way for a huge inoculation program to stem the coronavirus pandemic in the world’s second most populous country.India’s drugs regulator gave an emergency authorization for the vaccines developed by Oxford University and U.K.-based drugmaker AstraZeneca and another developed by the Indian company Bharat Biotech.Drugs Controller General Dr.

city New Delhi India covid-19 vaccine Coronavirus

AstraZeneca plans 2 million doses a week of COVID-19 vaccine for UK: Reports

COVID-19 vaccines in the UK, pharmaceutical companies have hit back at government claims that access to enough jabs was a "limiting factor", insisting there was no issue at their end.While AstraZeneca says it expects 2 million doses of the Oxford University vaccine to be ready each week in just over a fortnight, Pfizer BioNTech said the number of doses it has now sent to the UK is "in the millions".The Pfizer and Oxford/AstraZeneca jabs are the two vaccines against coronavirus that are approved for rollout in the UK."The plan is then to build it up fairly rapidly; by the third week of January we should get to 2 million a week," an AstraZeneca source told 'The Times' newspaper."The deliveries to the UK are on track and progressing according

Britain covid-19 vaccine Government

UK becomes first country to green-light AstraZeneca COVID vaccine

The United Kingdom today became the first country to approve the AstraZeneca-Oxford COVID-19 vaccine for emergency use, and its vaccine advisory group also recommended spacing out doses of it and the Pfizer-BioNTech vaccine to allow greater numbers of high-risk people to be vaccinated.

China city Wuhan, China Britain covid-19 vaccine

UK becomes first country to green-ight AstraZeneca COVID vaccine

China city Wuhan, China Britain covid-19 vaccine

Britain is first country to approve Oxford-AstraZeneca’s COVID-19 vaccine

The United Kingdom has become the first country to approve the COVID-19 vaccine from Oxford University and pharmaceutical company AstraZeneca. Redmond Shannon explains what makes this vaccine different from the others.

Britain city Redmond, county Shannon county Shannon city Oxford covid-19 vaccine

Oxford Covid-19 vaccine: AstraZeneca applies for European regulator's approval

AstraZeneca has submitted data of its Covid-19 vaccine for a conditional marketing authorisation application from the European Medicines Agency, a spokesman said on Wednesday."We can confirm that the we have submitted a full data package to support an application for conditional marketing authorisation for the AstraZeneca Covid-19 vaccine to the European Medicines Agency," the spokesman said.Also Read | Ten books from 2020 you must not miss"AstraZeneca has been submitting data on a rolling basis and will continue to work closely with the EMA to support the start of a formal CMA application process," he added.The vaccine is pending approval from Europe European Medicines Authority and the watchdog said that it needs additional data about the

covid-19 vaccine medicines Coronavirus

Oxford-AstraZeneca's coronavirus vaccine will be rolled out in UK from Monday

AstraZeneca-Oxford coronavirus vaccine are ready to be rolled out in the United Kingdom from Monday, Health Secretary Matt Hancock said after the shot was approved by the regulators."We'll get going on this from Monday," Hancock said while speaking to the BBC. "The number (of doses) that will be ready for next week is in the hundreds of thousands, and then the numbers increase."Also Read | Ten books from 2020 you must not missThe Oxford vaccine has got a green signal for use in Britain by the government after it was recommended for approval by the country's health regulator.

Matt Hancock Britain covid-19 vaccine

How Oxford- AstraZeneca covid-19 vaccine went from pole position to troubled start

LONDON : On June 5, researchers at the University of Oxford quietly made a change to a late-stage clinical trial of their COVID-19 vaccine. In an amendment noted in a document marked CONFIDENTIAL, they said they were adding a new group of participants.The adjustment might seem minor in a large-scale study.

Britain city Delhi city Oxford covid-19 testing vaccine

'North Korean hackers' target Brit Covid vaccine maker AstraZeneca in major cyberattack

North Korean hackers have targeted coronavirus vaccine maker AstraZeneca with bogus WhatsApp messages, according to claims.

Britain North Korea covid-19 vaccine Government Coronavirus

AstraZeneca says COVID-19 vaccine 'highly effective' prevention

LONDON - AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.The results are based on interim analysis of trials in the U.K. and Brazil of a vaccine developed by Oxford University and manufactured by AstraZeneca.

Brazil covid-19 vaccine

'Fantastic results': UK PM Boris Johnson on AstraZeneca's covid-19 vaccine news

Boris Johnson today hailed the "fantastic" news that AstraZeneca's covid-19 vaccine developed with the University of Oxford could be up to 90% effective, but said it still would require safety checks."Incredibly exciting news the Oxford vaccine has proved so effective in trials," Johnson said on Twitter. "There are still further safety checks ahead, but these are fantastic results."Incredibly exciting news the Oxford vaccine has proved so effective in trials.

Boris Johnson Britain city Oxford covid-19 vaccine Volunteers prevention

Oxford-AstraZeneca Covid-19 vaccine can be 90% effective, results show

covid vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen. The British-Swedish drugmaker's preliminary trial results mark a fresh breakthrough in the fight against a pandemic that has killed nearly 1.4 million people and roiled the global economy.

Pascal Soriot Sweden city Oxford covid-19 pandemic vaccine Coronavirus

AstraZeneca’s coronavirus vaccine produces strong immune response in older adults

AstraZeneca and Oxford University’s potential COVID-19 vaccine produced a strong immune response in older adults, data published on Thursday showed, with researchers expecting to release late-stage trial results by Christmas.The data, reported in part last month but published in full in The Lancet medical journal on Thursday, suggest that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.“The robust antibody and T-cell responses seen in older people in our study are encouraging,” said Maheshi Ramasamy, a consultant and co-lead investigator at the Oxford Vaccine Group.

covid-19 vaccine Coronavirus Vaccine Coronavirus

AstraZeneca pausing coronavirus vaccine trial after neurological symptoms found

coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent. AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon “We don’t know if it is (transverse myelitis),” Kent said.

covid-19 vaccine Coronavirus Vaccine Coronavirus

AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon

AstraZeneca should still know by year-end whether its experimental vaccine protects people against coronavirus, as long as it is cleared to resume trials soon, its chief executive said on Thursday amid doubts over its rollout.Governments desperate to put an end to the COVID-19 pandemic which has caused more than 900,000 deaths and huge economic and social disruption during 2020 are pinning their hopes on a vaccine.However British drugmaker AstraZeneca suspended late-stage trials on its potential vaccine this week after an illness in a participant in Britain who was reported to be suffering from symptoms associated with transverse myelitis, a rare spinal inflammatory disorder.

Britain Coronavirus Vaccine COVID-19 Vaccine Coronavirus

pharmaceutical-technology.com

19.08.2020 / 15:19

91%

545

Australia signs deal for AstraZeneca’s Covid-19 vaccine

Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The Australian Government has signed an agreement with AstraZeneca for the supply of the company’s Covid-19 vaccine candidate developed by the University of Oxford. This deal will provide the vaccine to every Australian for free, if found to be safe and effective in clinical trials, said the country’s Prime Minister Scott Morrison.

Scott Morrison Australia city Oxford covid-19 vaccine Government

EU agrees first Oxford Covid-19 vaccine deal with AstraZeneca in WHO blow

Brussels: The European Union has agreed to buy at least 300 million doses of AstraZeneca's potential COVID-19 vaccine in its first such advance purchase deal, which could weaken plans led by the World Health Organisation for a global approach.The European Commission, which is negotiating on behalf of all 27 EU member states, said the deal included an option to purchase 100 million additional doses from the British drugmaker should its vaccine prove safe and effective.The EU's bilateral deal mirrors moves by the United States and other wealthy states, some of which are critical of the WHO's initiative, and further reduces the potentially available stock in the race to secure effective COVID-19 vaccines.The EU agreement follows an initial

Usa India Britain Eu city Brussels covid-19 vaccine donates

AstraZeneca agrees to supply Europe with 400 million doses COVID-19 vaccine

ROME/BANGALORE : AstraZeneca Plc has signed a contract with European governments to supply the region with its potential vaccine against the coronavirus, the British drugmaker's latest deal to pledge its drug to help combat the pandemic.The contract is for up to 400 million doses of the vaccine, developed by the University of Oxford, the company said on Saturday, adding that it was looking to expand manufacturing of the vaccine, which it said it would provide for no profit during the pandemic.Deliveries will start by the end of 2020.The deal is the first contract signed by Europe's Inclusive Vaccines Alliance (IVA), a group formed by France, Germany, Italy and the Netherlands to secure vaccine doses for all member states as soon as

Italy Germany Britain France city Rome Netherlands city Bangalore city Oxford covid-19 vaccine Government Coronavirus

pharmaceutical-technology.com

05.06.2020 / 13:53

83%

619

AstraZeneca signs $750m Covid-19 vaccine manufacturing deal

UK and US. It is working towards a supply chain to ensure global access and has received manufacturing capacity for two billion of the vaccine’s doses to date.

Pascal Soriot Usa Britain covid-19 vaccine Volunteers

United States	Cases: 46 252 513 Deaths: 750 423 Recovered: 0
India	Cases: 34 321 025 Deaths: 459 652 Recovered: 0
Brazil	Cases: 21 835 785 Deaths: 608 235 Recovered: 0
United Kingdom	Cases: 9 215 683 Deaths: 141 607 Recovered: 0
Russia	Cases: 8 494 589 Deaths: 237 619 Recovered: 0

Latest news by search query "astrazeneca covid 19 vaccine"

Related News